Loading...
Cheiradone: a vascular endothelial cell growth factor receptor antagonist
BACKGROUND: Angiogenesis, the growth of new blood vessels from the pre-existing vasculature is associated with physiological (for example wound healing) and pathological conditions (tumour development). Vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2) and epidermal growt...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2008
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2248182/ https://ncbi.nlm.nih.gov/pubmed/18230134 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2121-9-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|